Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03854812Phase 2Completed
A Phase 2 trial of magnesium sulfate in chronic subdural hematoma (CSDH), sponsored by Kasr Al Ainy Hospital. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03854812.